Hims & Hers Health [HIMS] vs Interparfums [IPAR] Detailed Stock Comparison

Hims & Hers Health, Inc.

NYSE
Loading...

Interparfums Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Hims & Hers Health, Inc. wins in 3 metrics, Interparfums Inc. wins in 17 metrics, with 0 ties. Interparfums Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Hims & Hers Health, Inc. Interparfums Inc. Better
P/E Ratio (TTM) 55.20 18.17 Interparfums Inc.
Price-to-Book Ratio 11.83 3.47 Interparfums Inc.
Debt-to-Equity Ratio 207.16 18.82 Interparfums Inc.
PEG Ratio -2.21 1.15 Interparfums Inc.
EV/EBITDA 39.62 10.78 Interparfums Inc.
Profit Margin (TTM) 5.47% 11.31% Interparfums Inc.
Operating Margin (TTM) 2.72% 7.12% Interparfums Inc.
EBITDA Margin (TTM) 2.72% 7.12% Interparfums Inc.
Return on Equity 25.23% 20.34% Hims & Hers Health, Inc.
Return on Assets (TTM) 5.29% 11.28% Interparfums Inc.
Free Cash Flow (TTM) $57.42M $166.70M Interparfums Inc.
Dividend Yield N/A 4.25% N/A
1-Year Return -51.66% -25.19% Interparfums Inc.
Price-to-Sales Ratio (TTM) 2.73 2.05 Interparfums Inc.
Enterprise Value $6.96B $3.19B Hims & Hers Health, Inc.
EV/Revenue Ratio 2.97 2.14 Interparfums Inc.
Gross Profit Margin (TTM) 71.94% 61.46% Hims & Hers Health, Inc.
Revenue per Share (TTM) $10 $46 Interparfums Inc.
Earnings per Share (Diluted) $0.51 $5.24 Interparfums Inc.
Beta (Stock Volatility) 2.32 1.27 Interparfums Inc.
Short % of Float 38.71% 7.92% Interparfums Inc.

Hims & Hers Health, Inc. vs Interparfums Inc. Stock Performance Analysis

Loading Price Chart...

HIMS
IPAR

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Hims & Hers Health, Inc.12.49%11.04%20.44%21.26%-16.77%-9.70%
Interparfums Inc.-2.32%7.61%15.39%9.01%19.52%16.36%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Hims & Hers Health, Inc.-51.66%210.06%141.62%173.67%173.67%173.67%
Interparfums Inc.-25.19%-26.13%42.11%253.65%348.17%828.65%

Performance & Financial Health Analysis: Hims & Hers Health, Inc. vs Interparfums Inc.

MetricHIMSIPAR
Market Information
Market Cap i$6.42B$2.92B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i45,043,713214,009
90 Day Avg. Volume i34,338,941273,906
Last Close$30.17$99.42
52 Week Range$13.74 - $70.43$77.21 - $140.73
% from 52W High-57.16%-29.35%
All-Time High$72.98 (Feb 17, 2025)$161.17 (Apr 17, 2023)
% from All-Time High-58.66%-38.31%
Growth Metrics
Quarterly Revenue Growth0.28%0.07%
Quarterly Earnings Growth-0.21%0.16%
Financial Health
Profit Margin (TTM) i0.05%0.11%
Operating Margin (TTM) i0.03%0.07%
Return on Equity (TTM) i0.25%0.20%
Debt to Equity (MRQ) i207.1618.82
Cash & Liquidity
Book Value per Share (MRQ)$2.38$27.47
Cash per Share (MRQ)$2.53$9.25
Operating Cash Flow (TTM) i$300.01M$214.90M
Levered Free Cash Flow (TTM) i$110.51M$99.28M
Dividends
Last 12-Month Dividend Yield iN/A4.25%
Last 12-Month Dividend iN/A$4.00

Valuation & Enterprise Metrics Analysis: Hims & Hers Health, Inc. vs Interparfums Inc.

MetricHIMS (Apr 24, 2026)IPAR (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i55.2018.17
Forward P/E i19.8317.08
PEG Ratio i-2.211.15
Price to Sales (TTM) i2.732.05
Price to Book (MRQ) i11.833.47
Market Capitalization
Market Capitalization i$6.42B$2.92B
Enterprise Value i$6.96B$3.19B
Enterprise Value Metrics
Enterprise to Revenue i2.972.14
Enterprise to EBITDA i39.6210.78
Risk & Other Metrics
Beta i2.321.27
Book Value per Share (MRQ) i$2.38$27.47

Financial Statements Comparison: Hims & Hers Health, Inc. vs Interparfums Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricHIMS (2025)IPAR (2025)
Revenue/Sales i2.35B1.49B
Cost of Goods Sold i614.26M541.29M
COGS % of Revenue i26.2%36.4%
Gross Profit i1.73B947.22M
Gross Margin i73.8%63.6%
Research & Development i149.30MN/A
Operating Income (EBIT) i105.61M270.32M
Operating Margin i4.5%18.2%
EBITDA i155.68M308.66M
EBITDA Margin i6.6%20.7%
Pre-Tax Income i123.92M271.33M
Pre-Tax Income % of Revenue i5.3%18.2%
Income Tax i-4.44M63.19M
Income Tax % of Revenue i-0.2%4.2%
Net Income (Profit) i128.37M208.15M
Profit Margin i5.5%14.0%

Balance Sheet & Liquidity Metrics

MetricHIMS (2025)IPAR (2025)
Cash & Equivalents i228.62M158.09M
Total Current Assets i767.64M1.03B
Total Current Assets % of Revenue i32.7%69.0%
Total Current Liabilities i404.43M344.00M
Total Current Liabilities % of Revenue i17.2%23.1%
Long-Term Debt i1.12B137.22M
Long-Term Debt % of Revenue i47.5%9.2%
Total Shareholders Equity i540.93M1.10B
Retained Earnings i-113.77M828.91M
Retained Earnings % of Revenue i-4.8%55.7%
Property, Plant & Equipment i351.33M115.66M

Cash Flow Statement Comparison

MetricHIMS (2025)IPAR (2025)
Operating Cash Flow i400.85M254.67M
Operating Cash Flow % of Revenue i17.1%17.1%
Capital Expenditures i-226.05M-24.41M
Free Cash Flow i57.42M166.70M
FCF Margin i2.4%11.2%
Debt Repayment iN/A-50.32M
Common Stock Repurchase i-89.96M-13.87M

Short Interest & Institutional Ownership Analysis

MetricHIMSIPAR
Shares Short i71.36M1.43M
Short Ratio i1.975.15
Short % of Float i38.71%7.92%
Shares Outstanding i227.25M32.07M
Float Shares i207.36M18.10M
% Held by Insiders i5.48%43.64%
% Held by Institutions i85.92%64.33%
% Held by Public i8.60%-7.97%

Dividend Analysis & Yield Comparison: Hims & Hers Health, Inc. vs Interparfums Inc.

MetricHIMSIPAR
Last 12-Month Dividend iN/A$4.00
Last 12-Month Dividend Yield iN/A4.25%
3-Year Avg Annual Dividend iN/A$3.16
3-Year Avg Dividend Yield iN/A0.62%
3-Year Total Dividends iN/A$9.48
Ex-Dividend DateN/AMar 16, 2026